[1]Patent:WO2012/93809,2012,A2.Locationinpatent:Page/Pagecolumn26-27
[2]Patent:US2013/274268,2013,A1.Locationinpatent:Paragraph0192-0194
603143-27-7
648904-85-2
1355011-25-4
1436431-16-1
2121513-47-9
1389264-15-6 | 6-Oxa-2-azaspiro[3.5]nonane oxalate | AA0019RV | MFCD22415255
1391547-09-3 | (S)-Methyl 4-(piperidin-2-yl)benzoate hydrochloride | AA001ACA | MFCD12910878
13935-00-7 | Sodium 4-hydroxynaphthalene-2-sulfonate | AA001AQI | MFCD00064963
139551-83-0 | Fmoc-L-leucinol | AA001B6Y | MFCD00235932
139937-37-4 | 4-Bromo-2-methylbenzene-1-sulfonyl chloride | AA001BR8 | MFCD00219927
1401426-05-8 | 1-(1-Methyl-1h-pyrazol-4-yl)cyclopropanamine dihydrochloride | AA001BZS | MFCD20441460
140614-19-3 | (2-Ethylbutyl)boronic acid | AA001CHF | MFCD22190244
1408075-88-6 | Methyl 3-oxo-1-methyl-cyclobutanecarboxylate | AA001CQV | MFCD23105986
1455-05-6 | 2-Chloroethylphosphoric acid dichloride | AA001D1R | MFCD00013898
145821-59-6 | Tiagabine hydrochloride | AA001DD2 | MFCD07369025